AC, W., SR, M., J, S., LA, C., AJ, C., MJ, S., & RW, J. (2013). An intact immune system is required for the anticancer activities of histone deacetylase inhibitors. Cancer research, 73(24), 7265. https://doi.org/10.1158/0008-5472.CAN-13-0890
Chicago Style (17th ed.) CitationAC, West, Mattarollo SR, Shortt J, Cluse LA, Christiansen AJ, Smyth MJ, and Johnstone RW. "An Intact Immune System Is Required for the Anticancer Activities of Histone Deacetylase Inhibitors." Cancer Research 73, no. 24 (2013): 7265. https://doi.org/10.1158/0008-5472.CAN-13-0890.
MLA (9th ed.) CitationAC, West, et al. "An Intact Immune System Is Required for the Anticancer Activities of Histone Deacetylase Inhibitors." Cancer Research, vol. 73, no. 24, 2013, p. 7265, https://doi.org/10.1158/0008-5472.CAN-13-0890.